|Bid||1.5000 x 14831600|
|Ask||1.6300 x 5161300|
|Day's range||1.3800 - 1.6300|
|52-week range||1.1750 - 9.4505|
|Beta (5Y monthly)||1.12|
|PE ratio (TTM)||N/A|
|Earnings date||23 Feb 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||13.03|
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, although...
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF), a global leader in the research and development of clinically validated cannabinoid medicines, is pleased to announce the US launch of the Zelira Dermatology Business' first product line, RAF FIVE™, through its dermatology subsidiary Ilera Derm LLC ("Zelira Dermatology").
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...